Press release
Cholera Vaccine Market To See Record Break Revenue $207 Million By 2025 | Valneva SE, Astellas Pharma, Inc
Cholera Vaccine Market
The global cholera vaccine market contributed nearly $65 million in 2017 and is expected to reach $207 million by 2025, registering a CAGR of 15.6% from 2018 to 2025.
Download Detailed COVID-19 Impact Sample Report at @ https://www.alliedmarketresearch.com/request-for-customization/5177?reqfor=covid
COVID-19 scenario-
1) Due to the global pandemic all over the world, the medical devices manufacturers are majorly focusing on essential medical devices production including ventilators and diagnostics.
2) However, due to the precautionary measures taken by governments in various regions, the supply chain has been hampered. Which may result in shortage of devices in certain locations.
3) Food and Drugs Administration (FDA), on the other hand, shared a COVID-19 guidance with medical device manufacturers to notify the agency about changes that could affect availability of their products.
However, time taken for regulatory approvals and risks related to adverse effects restrain the market growth. On the other hand, opportunities in emerging economies create new pathways in the industry.
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/5177
Dukoral to maintain its dominant share by 2025
Dukoral contributed the highest market share of nearly half of the total market in 2017 and is expected to maintain its dominant share by 2025. This is due to the established pile of the oral cholera vaccine by the World Health Organization (WHO) and rise in the number of travelers to the low- and middle-income countries (LMICs). However, Vaxchora is expected to register the highest growth rate, with a CAGR of 17.2% from 2018 to 2025, owing to its benefits such as single dose immunization, reduction in adverse effects, and high efficacy rate for prevention of cholera.
Hospitals and clinics to maintain its lead status throughout the forecast period
Hospitals and clinics accounted for nearly three-fifths of the total market share in 2017 and will maintain its lead status throughout the forecast period. This is due to increase in the incidences of cholera, demand for immunization, the availability of highly-skilled and qualified professionals in the hospitals, and preference of patients. However, the research & academic laboratories segment is expected to grow at a CAGR of 16.4% during the forecast period, owing to surge in demand for cholera vaccine across the globe for more effective and cost efficient cholera vaccines.
North America to grow fastest
North America is expected to grow at the highest growth rate, with a CAGR of 15.4% from 2018 to 2025, owing to the launch of Vaxchora, the first and only oral cholera vaccine in the U.S. and the increase in immunization. However, Asia-Pacific contributed nearly two-fifths of the total market share in 2017 and will lead throughout the forecast period. This is due to rise in prevalence of cholera disease in low-and middle-income countries leading to the increase in importance of immunization, surge in healthcare spending, and upsurge in awareness regarding cholera preventive care.
To know more about the report, visit the website at @ https://www.alliedmarketresearch.com/cholera-vaccine-market
The Major Key Players Are:
Valneva SE, Emergent BioSolutions, Inc. (PaxVax, Inc.), Astellas Pharma, Inc., Sanofi (Shantha Biotechnics Private Limited), Eubiologics Co., Ltd., and Johnson & Johnson (Crucell), Celldex Therapeutics, Inc.
The other Key players are:
Merck & Co., Inc., GlaxoSmithKline plc., and others
Similar Reports:
Alopecia Treatment Market : https://www.pharmiweb.com/press-release/2020-09-29/alopecia-treatment-market-top-companies-analysis-to-growing-at-cagr-of-46-by-2026
India Medical Implants Market : https://www.pharmiweb.com/press-release/2020-09-29/india-medical-implants-market-top-companies-analysis-to-grow-your-business-in-2027-1
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cholera Vaccine Market To See Record Break Revenue $207 Million By 2025 | Valneva SE, Astellas Pharma, Inc here
News-ID: 2255206 • Views: …
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for Cholera
Hog Cholera Vaccine Market Increasing concerns over hog cholera outbreaks and th …
Global Hog Cholera Vaccine Market Overview:
The Hog Cholera Vaccine market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Hog Cholera Vaccine market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and globalization. This growth…
Global Cholera Treatment Market Scope and Market Size
Data Bridge Market Research analyses that the cholera treatment will exhibit a CAGR of around 8.58% for the forecast period of 2021-2028. Growing demand for target mode of therapies, increased focus on the strategic initiatives by the market players to initiate new product launches, surge in the research and development activities for the development of novel drugs and therapies, high demand for drugs used to treat risks associated with tularemia…
Oral Cholera Vaccine Market is Thriving Worldwide with Top Companies like: Sanof …
Los Angeles, United State, –The report titled Global Oral Cholera Vaccine Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Oral Cholera Vaccine market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of…
Cholera Treatment Market Growth Report 2016- 2024
Cholera disease spreads because of contamination of water and food and is closely associated with poor sanitation and lack of clean drinking water. The global disease burden is around 3–5 million cases and 100 000– 130 000 deaths per year. In recent time the frequency of cholera epidemics has increased. The disease is caused by Vibrio cholerae a rod-shaped waterborne bacterium. The toxins released by bacterium causes loss of intravascular…
Cholera Treatment Market, Industry Research report, Forecasts upto 2024
Cholera disease spreads because of contamination of water and food and is closely associated with poor sanitation and lack of clean drinking water. The global disease burden is around 3–5 million cases and 100 000– 130 000 deaths per year. In recent time the frequency of cholera epidemics has increased. The disease is caused by Vibrio cholerae a rod-shaped waterborne bacterium. The toxins released by bacterium causes loss of intravascular…
Cholera Treatment Market: Opportunities and Forecasts, 2014
Cholera disease spreads because of contamination of water and food and is closely associated with poor sanitation and lack of clean drinking water. The global disease burden is around 3–5 million cases and 100 000– 130 000 deaths per year. In recent time the frequency of cholera epidemics has increased. The disease is caused by Vibrio cholerae a rod-shaped waterborne bacterium. The toxins released by bacterium causes loss of intravascular…
